Understanding Covid‐19 pathophysiology is crucial for a better understanding of the
disease and development of more effective treatments. Alpha‐1‐antitrypsin (A1AT) is a …

Alpha-1 antitrypsin (AAT) deficiency is a hereditary condition characterized by low levels of
AAT in plasma and hence diffusion into tissues. One of the most relevant characteristics of …

Panniculitis is a recognized but unusual complication of a severe deficiency of α 1-
antitrypsin (AAT), with fewer than 100 cases described to date. Like the pathogenesis of …

Abstract Background α1-antitrypsin (AAT) serves primarily as an inhibitor of the elastin
degrading proteases, neutrophil elastase and proteinase 3. There is ample clinical evidence …

El déficit de alfa-1-antitripsina (DAAT) es la enfermedad congénita potencialmente mortal
más frecuente en la edad adulta. A pesar de ello, continúa siendo una enfermedad …

Introduction α1-antitrypsin (AAT) deficiency is the most common potentially fatal hereditary
disease in the adult population. Despite this, the condition continues to be underdiagnosed …

Alpha-1-antitrypsin deficiency (AATD) is a rare genetic disorder associated with the
development of liver and lung disease. AAT is a 52-kD glycoprotein, produced mainly by …

Nosocomial pneumonia (NP) is the third most common hospital-acquired infection and the
leading cause of death due to hospital-acquired infection in the US. During pneumonia and …

Abstract α1‐Antitrypsin deficiency (AATD) predisposes individuals to chronic obstructive
pulmonary disease (COPD) and liver disease. Despite being commonly described as rare …

Alpha-1 antitrypsin (A1AT) is a 52-kDa, acute phase glycoprotein encoded by the protease
inhibitor (PI) locus, located on the long arm of chromosome 14 (14q31-32.3). Its structure is …